beLAB1407 Introduction Seminar



  • Monday, 21/06/2021
  • 16:00 - 17:00

Event Description {{detailsExpanded ? '- Show Less' : '+ Show More'}}

21EDIN12_beLAB_event_email_header_b.png

Biomedical researchers are invited to join Dr Mark Slack from Evotec and Professor Scott Webster to learn about beLAB1407, the recently launched partnership between the University of Edinburgh, Evotec and Bristol Myers Squibb to support drug discovery projects from early idea to formation of a spinout company.

beLAB1407 is a great opportunity to access significant funding of between £100K -£1.25M into early stage drug discovery projects for acceleration to clinic as well as mentoring and technical support.

Dr Mark Slack will introduce the concept of BeLab1407, the process and support available from this innovative partnership while Dr Scott Webster will outline his role and ambitions for drug discovery projects at the university.

Dr Slack and Professor Webster will be available for a short Q&A and discussion session at the end of the webinar, answering any questions you might have about how to engage with support from beLAB1407.

The beLAB1407 website provides an overview of the scheme and the opportunities provided. 

Please register below to attend the event.

For assistance, please contact us on eievents@ei.ed.ac.uk



You aren't logged in

Login to register

View Other Events



Edinburgh Innovations Limited is the University of Edinburgh’s commercialisation service. Edinburgh Innovations is a wholly owned subsidiary company of the University of Edinburgh. Your data will be held securely and will not be passed on to any third parties. Consent can be withdrawn at any time and all marketing communications will include an unsubscribe link. Please view our privacy notice to understand how we use and protect the information that you provide to us.

© 2021 - EI Ltd, The University of Edinburgh